adverse effect of semaglutide icd 10 HCGTV: Webinar Snippet - 2026 Q1 ICD-10 Updates Glucagon‐Like Peptide‐1 Receptor Agonist Use

Marx-Schtt has received personal fees for lectures from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Lilly, MSD, Novo Nordisk, Novartis, OmniaMed and served as an advisor for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim and Novo Nordisk

If you see particles, cloudiness, or discoloration, do not use the vial

If you need to stop the medication, your healthcare provider will guide you through a gradual tapering process to ensure safety and minimize discomfort

Understanding potential side effects is critical for making informed treatment choices

Significant reduction in all-cause mortality with Ozempic 1 For adults with T2D and CKD for a confirmatory secondary endpoint: time to first occurrence of all-cause mortality vs placebo when both were added to standard of care 1,2 All cause death 1-3 1-3 cc 2.5% ARR reported at 3 years in pre-specified supplementary analysis